Physician profile
Matthew A Will
NPI 1083835730
$1,361.18
in general payments reported to CMS, 2019-2025
8 companies · $392 in 2025
The $392 reported for 2025 was more than what 83% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $43.57 · 2021: $284 · 2022: $47.62 · 2023: $89.04 · 2024: $236 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $298.06 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $260.19 | 2021-2025 | Stripper |
| Emd Serono, INC. | $246.27 | 2019-2024 | |
| Organon LLC | $200.76 | 2023-2025 | Ganirelix Acetate, Pregnyl, Follistim Aq |
| Hologic Sales and Service, LLC | $196.43 | 2019-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Omni Hysteroscope |
| Medtronic, INC. | $127.09 | 2021 | |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Merck Sharp & Dohme LLC | $16.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Will listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.